TLSA

Tiziana Life Sciences (TLSA)

About Tiziana Life Sciences (TLSA)

Tiziana Life Sciences Ltd. is a clinical-stage biotechnology company, which engages in developing therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, Amyotrophic Lateral Sclerosis, and Alzheimer’s. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom.

Details

Daily high

$1.58

Daily low

$1.45

Price at open

$1.54

52 Week High

$2.60

52 Week Low

$0.63

Market cap

177.2M

Dividend yield

0.00%

Volume

264,702

Avg. volume

426,780

P/E ratio

-13.91

Tiziana Life Sciences News